Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Business
Holly Williams

AstraZeneca ditches lung cancer treatment trial

Drug giant AstraZeneca has revealed its latest drug setback in just over a month after halting a late stage lung cancer treatment trial (PA) - (PA Archive)

Drug giant AstraZeneca has revealed its latest setback in just over a month after halting a late stage lung cancer treatment trial.

The FTSE 100 firm said it found its Volrustomig drug, when combined with chemotherapy, was unlikely to boost survival rates for lung cancer patients when compared with another existing treatments.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.